15644074

Source:http://linkedlifedata.com/resource/pubmed/id/15644074

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:15644074	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:15644074	lifeskim:mentions	umls-concept:C0026896	lld:lifeskim
pubmed-article:15644074	lifeskim:mentions	umls-concept:C0205470	lld:lifeskim
pubmed-article:15644074	lifeskim:mentions	umls-concept:C0302350	lld:lifeskim
pubmed-article:15644074	lifeskim:mentions	umls-concept:C0205210	lld:lifeskim
pubmed-article:15644074	lifeskim:mentions	umls-concept:C0725066	lld:lifeskim
pubmed-article:15644074	pubmed:issue	2	lld:pubmed
pubmed-article:15644074	pubmed:dateCreated	2005-1-12	lld:pubmed
pubmed-article:15644074	pubmed:abstractText	We give an update on clinical, immunological, and therapeutic advances in the field of myasthenia gravis, including a summary of suggested therapeutic recommendations.	lld:pubmed
pubmed-article:15644074	pubmed:language	eng	lld:pubmed
pubmed-article:15644074	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15644074	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:15644074	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15644074	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15644074	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15644074	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:15644074	pubmed:month	Feb	lld:pubmed
pubmed-article:15644074	pubmed:issn	0001-6314	lld:pubmed
pubmed-article:15644074	pubmed:author	pubmed-author:AarliJ AJA	lld:pubmed
pubmed-article:15644074	pubmed:author	pubmed-author:GilhusN ENE	lld:pubmed
pubmed-article:15644074	pubmed:author	pubmed-author:RomeJJ	lld:pubmed
pubmed-article:15644074	pubmed:issnType	Print	lld:pubmed
pubmed-article:15644074	pubmed:volume	111	lld:pubmed
pubmed-article:15644074	pubmed:owner	NLM	lld:pubmed
pubmed-article:15644074	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:15644074	pubmed:pagination	134-41	lld:pubmed
pubmed-article:15644074	pubmed:dateRevised	2006-8-16	lld:pubmed
pubmed-article:15644074	pubmed:meshHeading	pubmed-meshheading:15644074...	lld:pubmed
pubmed-article:15644074	pubmed:meshHeading	pubmed-meshheading:15644074...	lld:pubmed
pubmed-article:15644074	pubmed:meshHeading	pubmed-meshheading:15644074...	lld:pubmed
pubmed-article:15644074	pubmed:meshHeading	pubmed-meshheading:15644074...	lld:pubmed
pubmed-article:15644074	pubmed:meshHeading	pubmed-meshheading:15644074...	lld:pubmed
pubmed-article:15644074	pubmed:meshHeading	pubmed-meshheading:15644074...	lld:pubmed
pubmed-article:15644074	pubmed:meshHeading	pubmed-meshheading:15644074...	lld:pubmed
pubmed-article:15644074	pubmed:year	2005	lld:pubmed
pubmed-article:15644074	pubmed:articleTitle	Myasthenia gravis: clinical, immunological, and therapeutic advances.	lld:pubmed
pubmed-article:15644074	pubmed:affiliation	Department of Neurology, Haukeland University Hospital, Bergen, Norway. fredrik.romi@haukeland.no	lld:pubmed
pubmed-article:15644074	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:15644074	pubmed:publicationType	Review	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15644074	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15644074	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15644074	lld:pubmed